CIPARS-VASR: Veterinary Antimicrobial Sales Reporting in Canada:

The VASR system collects data annually on volumes of antimicrobials and quantity sold or compounded by animal species and by province/territory. The reporting year reflects data collected for the period of January 1 to December 31.

Starting in 2018, the Food and Drug Regulations require manufacturers, importers and compounders to report annual sales of List A ingredients (Health Canada’s Category I, II, III, and Uncategorized Medically Important Antimicrobials) intended for use in animals. To meet this requirement, the Public Health Agency of Canada and Health Canada designed and developed the online reporting tool, the Veterinary Antimicrobial Sales Reporting (VASR) system.

The information on this page includes the quantity of sales (measured in kilograms) of medically important antimicrobials by manufacturers and importers, and excludes compounders (unless otherwise noted).

CIPARS-VASR reports the quantity of antimicrobials sold in four ways: 1) total kilograms, 2) milligrams per Canadian PCU (mg/PCU_CA), 3) milligrams per European PCU (mg/PCU_EU), and 4) milligrams per biomass at slaughter (mg/biomass_SL). The population correction unit (PCU) is a measure of animal biomass that accounts for the number of animals and their average weight at treatment (using either average Canadian or European weights). The biomass at slaughter is a measure of animal biomass that accounts for the number of production animals and their Canadian average weight at slaughter. Production animals include both horses and food animals (beef and dairy cattle, veal calves, poultry, pigs, sheep, goats, and aquaculture).

For additional information, please visit the Public Health Agency of Canada’s Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) and Health Canada’s Veterinary Antimicrobial Sales Reporting (VASR).

The interactive visualizations are updated regularly, and therefore may differ from published CIPARS reports.

Figure 1. CIPARS-VASR: Annual quantity in of medically important antimicrobials sold by manufacturers and importers for use in , Canada.

Table 1. CIPARS-VASR: Annual quantity of medically important antimicrobials sold by manufacturers and importers for use in animals, Canada

Figure 1: Text description

Year	Quantity of antimicrobials sold (kg)
Year	All animals	Production animals

Figure 2. CIPARS-VASR: Annual quantity in of medically important antimicrobials sold by manufacturers and importers by Health Canada's Category of Importance in Human Medicine, for use in , Canada.

Hover over the line graph to see the annual quantity of antimicrobials sold by manufacturers and importers. Click on a legend element to add or remove the corresponding lines from the graph.

Health Canada's Categorization of Antimicrobial Drugs based on Importance in Human Medicine

Table 2. CIPARS-VASR: Annual quantity (kg) of medically important antimicrobials sold by manufacturers and importers by Health Canada's Category of Importance in Human Medicine, for use in animals, Canada.

Figure 2: Text description

Year	Quantity of antimicrobials sold (kg) for use in all animals
Year	Category I	Category II	Category III	Uncategorized Medically Important

Figure 3. CIPARS-VASR: Annual quantity in of medically important antimicrobials sold by manufacturers and importers for use in , by antimicrobial class, Canada.

Add or remove items from the chart below by selecting or deselecting items from this list:

Antimicrobial classes with fewer than three companies reporting are grouped together as Not Independently Reported (NIR) to prevent identification of individual company’s sales volumes. Antimicrobial classes included in NIR: aminocoumarins, bacitracins, diaminopyrimidines, fusidic acid, glycopeptides, nitroimidazoles, orthosomycins, phosphonic acid derivatives, pleuromutilins, pseudomonic acids, streptogramins, and therapeutic agents for tuberculosis.

Table 3. CIPARS-VASR: Annual quantity of medically important antimicrobials sold by manufacturers and importers for use in animals, by antimicrobial class, Canada.

Figure 3: Text description

Antimicrobial class	Quantity of antimicrobials sold (kg) for use in all animals
Antimicrobial class	2018	2019	2022	2021	2022

Figure 4. CIPARS-VASR: Quantity in of medically important antimicrobials sold by manufacturers and importers by species, Canada.

Hover over the line graph to see the annual quantity of antimicrobials sold by manufacturers and importers. Click on a legend element to add or remove the corresponding lines from the graph.

Table 4. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers by species, Canada.

Figure 4: Text description

Species	Quantity of antimicrobials sold (kg)
Species	2018	2019	2022	2021	2022

Figure 5. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers, by province, in Canada, in .

The Atlantic Provinces include New Brunswick, Nova Scotia, Newfoundland and Labrador, and Prince Edward Island. Nunavut and the Territories are excluded due to confidentiality.

Table 5. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers, by province, Canada.

Figure 5: Text description

Province/Region	Quantity of antimicrobials sold (kg) by year
Province/Region	2018	2019	2022	2021	2022

Figure 6. CIPARS-VASR: The percentage of total sales (in kg) of medically important antimicrobials by manufacturers and importers, by route of administration, in Canada, in .

Other oral includes tablets, capsules, boluses, oral paste and oral powders/solutions for individual administration. Other routes includes topical, ophthalmic, otic, intramammary, intrauterine and other routes.

Table 6. CIPARS-VASR: The percentage of total sales (in kg) of medically important antimicrobials by manufacturers and importers, by route of administration, Canada.

Figure 6: Text description

Route of administration	Quantity of antimicrobials sold (kg) by year
Route of administration	2018	2019	2022	2021	2022

Did you find what you were looking for?

What was wrong?

The answer I need is missing

The information isn’t clear

I’m not in the right place

Something is broken or incorrect

Other reason

Please provide more details

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Date modified:: 2024-01-29

Language selection

Search

CIPARS-VASR: Veterinary Antimicrobial Sales Reporting in Canada:

Figure 1. CIPARS-VASR: Annual quantity in of medically important antimicrobials sold by manufacturers and importers for use in , Canada.

Table 1. CIPARS-VASR: Annual quantity of medically important antimicrobials sold by manufacturers and importers for use in animals, Canada

Figure 2. CIPARS-VASR: Annual quantity in of medically important antimicrobials sold by manufacturers and importers by Health Canada's Category of Importance in Human Medicine, for use in , Canada.

Table 2. CIPARS-VASR: Annual quantity (kg) of medically important antimicrobials sold by manufacturers and importers by Health Canada's Category of Importance in Human Medicine, for use in animals, Canada.

Figure 3. CIPARS-VASR: Annual quantity in of medically important antimicrobials sold by manufacturers and importers for use in , by antimicrobial class, Canada.

Table 3. CIPARS-VASR: Annual quantity of medically important antimicrobials sold by manufacturers and importers for use in animals, by antimicrobial class, Canada.

Figure 4. CIPARS-VASR: Quantity in of medically important antimicrobials sold by manufacturers and importers by species, Canada.

Table 4. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers by species, Canada.

Figure 5. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers, by province, in Canada, in .

Table 5. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers, by province, Canada.

Figure 6. CIPARS-VASR: The percentage of total sales (in kg) of medically important antimicrobials by manufacturers and importers, by route of administration, in Canada, in .

Table 6. CIPARS-VASR: The percentage of total sales (in kg) of medically important antimicrobials by manufacturers and importers, by route of administration, Canada.

You might also be interested in

CIPARS Antimicrobial Resistance (AMR)

Antimicrobial use (AMU) in the Canadian community sector

Did you find what you were looking for?

CIPARS-VASR: Veterinary Antimicrobial Sales Reporting in Canada:

Figure 1. CIPARS-VASR: Annual quantity in kilograms mg per Canadian PCU mg per European PCU mg per biomass at slaughter of medically important antimicrobials sold by manufacturers and importers for use in all animals production animals , Canada.

Table 1. CIPARS-VASR: Annual quantity of medically important antimicrobials sold by manufacturers and importers for use in animals, Canada

Table 2. CIPARS-VASR: Annual quantity (kg) of medically important antimicrobials sold by manufacturers and importers by Health Canada's Category of Importance in Human Medicine, for use in animals, Canada.

Figure 3. CIPARS-VASR: Annual quantity in kilograms mg per Canadian PCU mg per European PCU mg per biomass at slaughter of medically important antimicrobials sold by manufacturers and importers for use in all animals production animals , by antimicrobial class, Canada.

Table 3. CIPARS-VASR: Annual quantity of medically important antimicrobials sold by manufacturers and importers for use in animals, by antimicrobial class, Canada.

Figure 4. CIPARS-VASR: Quantity in kilograms mg per Canadian PCU mg per European PCU mg per biomass at slaughter of medically important antimicrobials sold by manufacturers and importers by species, Canada.

Table 4. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers by species, Canada.

Figure 5. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers, by province, in Canada, in 2018 2019 2020 2021 2022 .

Table 5. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers, by province, Canada.

Figure 6. CIPARS-VASR: The percentage of total sales (in kg) of medically important antimicrobials by manufacturers and importers, by route of administration, in Canada, in 2018 2019 2020 2021 2022 .

Table 6. CIPARS-VASR: The percentage of total sales (in kg) of medically important antimicrobials by manufacturers and importers, by route of administration, Canada.

You might also be interested in

CIPARS Antimicrobial Resistance (AMR)

Antimicrobial use (AMU) in the Canadian community sector

Did you find what you were looking for?

Figure 1. CIPARS-VASR: Annual quantity in of medically important antimicrobials sold by manufacturers and importers for use in , Canada.

Figure 3. CIPARS-VASR: Annual quantity in of medically important antimicrobials sold by manufacturers and importers for use in , by antimicrobial class, Canada.

Figure 4. CIPARS-VASR: Quantity in of medically important antimicrobials sold by manufacturers and importers by species, Canada.

Figure 5. CIPARS-VASR: Quantity of medically important antimicrobials sold by manufacturers and importers, by province, in Canada, in .

Figure 6. CIPARS-VASR: The percentage of total sales (in kg) of medically important antimicrobials by manufacturers and importers, by route of administration, in Canada, in .